- 선택됨
상세정보
-
학력
- 고신대학교 의과대학 졸업(1989년)
- 고신대학교 대학원 의학석사(1997년)
- 부산대학교 대학원 의학박사(2001년)
- 부산대 자연과학대 분자생물학과 박사(2002년)
-
경력
- 서울아산병원 소화기내과 전임의 (1996년 - 1998년)
- 미국 베데스다 국립암센터 연수(2003년 - 2004년)
- 울산의대 울산대병원 소화기내과(1998년 - 현재)
- 논문 100여편의 SCI 논문 발표
- 대한간학회 간상학술상 수상
- 울산 내과학회 및 부산·울산·경남 간학회 회장 역임
- 생물학연구정보센터(BRIC)의 한국을 빛내는 사람들 등재
- 의학연구실장 및 생의과학연구소장(현재)
- 대한 간학회 전산정보이사(현재)
- 울산대학교병원 소화기내과 교수(현재)
논문
- The risk of hepatocellular carcinoma within and beyond the first 5 years of entecavir in Korean patients with chronic hepatitis B. Kim BG, Park NH, Lee SB, Jeon S, Park JH, Jung SW, Jeong ID, Bang SJ, Shin JW. Liver Int. 2018 Jul 27. (IF 4.5 교신저자)
- Mortality, liver transplantation and hepatic complications in patients with treatment-naïve chronic hepatitis B treated with entecavir vs tenofovir. Kim BG, Park NH, Lee SB, Lee H, Lee BU, Park JH, Jung SW, Jeong ID, Bang SJ, Shin JW. J Viral Hepat. 2018 Jul 11. (IF 4.2 교신저자)
- Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir. Shin JW, Jung SW, Lee SB, Lee BU, Park BR, Park EJ, Park NH. Am J
- Gastroenterol. 2018 Jul;113(7):998-1008. (IF 10.2 교신저자)
- Tonicity-responsive enhancer-binding protein promotes hepatocellular carcinogenesis, recurrence and metastasis. Lee JH, Suh JH, Choi SY, Kang HJ, Lee HH, Ye BJ, Lee GR, Jung SW, Kim CJ, Lee-Kwon W, Park J, Myung K, Park NH, Kwon HM. Gut. 2018 Feb 2. (IF 17.0 교신저자)
- Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study. Lee SB, Park GM, Lee JY, Lee BU, Park JH, Kim BG, Jung SW, Jeong ID, Bang SJ, Shin JW, Park NH, Yang DH, Kang JW, Lim TH, Kim HK, Choe J, Lee HC. J Hepatol. 2018 May;68(5):1018-1024. (IF 14.9 공동저자)
- Identification of additional EHMT2 variant associated with the risk of chronic hepatitis B by GWAS follow-up study. Shin JG, Cheong HS, Kim JY, Lee JH, Yu SJ, Yoon JH, Cheong JY, Cho SW, Park NH, Namgoong S, Kim LH, Kim YJ, Shin HD. Genes Immun. 2017 Dec 14.
- Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naïve Patients with Chronic Hepatitis B. Du Jeong I, Jung SW, Park BR, Lee BU, Park JH, Kim BG, Bang SJ, Shin JW, Park NH. Dig Dis Sci. 2017 Oct;62(10):2908-2914.
- Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir. Jeon HJ, Jung SW, Park NH, Yang Y, Noh JH, Ahn JS, Kim HR, Lee JH, Shin JW. Clin Mol Hepatol. 2017 Sep;23(3):230-238.
- DRG2 Regulates G2/M Progression via the Cyclin B1-Cdk1 Complex. Jang SH, Kim AR, Park NH, Park JW, Han IS. Mol Cells. 2016 Sep;39(9):699-704
- Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population. Shin JG, Cheong HS, Lee K, Ju BG, Lee JH, Yu SJ, Yoon JH, Cheong JY, Cho SW, Park NH, Namgoong S, Kim LH, Kim YJ, Shin HD. Liver Int. 2017 Mar;37(3):354-361.
- Clinical Application of Non-invasive Diagnostic Tests for Liver Fibrosis. Shin JW, Park NH. Korean J Gastroenterol. 2016 Jul 25;68(1):4-9.
- Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B. Park CH, Jung SW, Shin JW, Bae MA, Lee YI, Park YT, Chung HS, Park NH. Clin Mol Hepatol. 2016 Mar;22(1):152-9
- Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth. Kim J, Kim W, Moon UJ, Kim HJ, Choi HJ, Sin JI, Park NH, Cho HR, Kwon B. J Immunol. 2016 Mar 1;196(5):2410-23. (공동저자) (IF 4.98)
- Kim CJ, Shin JW, Jung SW, Park BR, Park NH. Somatic mutation of ARHI gene in Hepatocellular Carcinomas. Pathology & Oncology Research. 2015;21:1277-9. (교신저자) (IF 1.94)
- Kim JH, Jung SW, Byun SS, Shin JW, Park BR, Kim MH, Kim CJ, Park NH. Efficacy and safety of tenofovir in nucleos(t)ide-naïve patients with genotype C chronic hepatitis B in real-life practice. Int J Clin Pharm. 2015;37:1228-34 (교신저자)
- Kim BG, Jung SW, Kim EH, Kim JH, Park JH, Sung SJ, Park BY, Kim MH, Kim CJ, Lee BK, Park JH, Jeong ID, Bang SJ, Shin JW, Park NH. Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir. J Gastroenterol Hepatol. 2015;30:1514-21. (교신저자)
- Park JH, Kim BG, Jung SW, Kim EH, Kim JH, Park JH, Sung SJ, Park BY, Kim MH, Kim CJ, Lee BK, Jeong ID, Bang SJ, Shin JW, Park NH. Efficacy of Tenofovir Based Rescue Therapy in Lamivudine Resistant Chronic Hepatitis B Patients with Failure of Lamivudine and Adefovir Combination. Clinical Therapeutics. 2015; 37:1433-42 (교신저자)
- Kim LH, Cheong HS, Namgoong S, Kim JO, Kim JH, Park BL, Cho SW, Park NH, Cheong JY, Koh I, Shin HD, Kim YJ. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population. Infect Genet Evol. 2015;33:72-6.
- Yuen MF, Ahn SH, Lee KS, Um SH, Cho M, Yoon SK, Lee JW, Park NH, Kweon YO, Sohn JH, Lee J, Kim JA, Lai CL, Han KH. Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: Results from a multicentre study. J Hepatol. 2015;62(3):526-32.
- Cheong HS, Lee JH, Yu SJ, Yoon JH, Lee HS, Cheong JY, Cho SW, Park NH, Park BL, Namgoong S, Kim LH, Shin HD, Kim YJ. Association of VARS2-SFTA2 polymorphisms with the risk of chronic hepatitis B in a Korean population. Liver Int. 2015; 48:76-81.(IF 4.47)
- Jin YJ, Lee D, Chung YH, Kim JA, Kim SE, Lee YS, Shin ES, Ryu SH, Jang MK, Lee JE, Park NH. Tumor Necrosis Factor-Alpha Gene Polymorphism Associated With Development of Hepatitis B Virus-associated Hepatocellular Carcinoma. J Clin Gastroenterol. 2015; 49:76-81.
- Lee GR, Jang SH, Kim CJ, Kim AR, Yoon DJ, Park NH, Han IS. Capsaicin suppresses the migration of cholangiocarcinoma cells by down-regulating matrix metalloproteinase-9 expression via the AMPK-NF-κB signaling pathway. Clin Exp Metastasis. 2014;31(8):897-907. (교신저자)
- Meerzaman DM, Yan C, Chen QR, Edmonson MN, Schaefer CF, Clifford RJ, Dunn BK, Dong L, Finney RP, Cultraro CM, Hu Y, Yang Z, Nguyen CV, Kelley JM, Cai S, Zhang H, Zhang J, Wilson R, Messmer L, Chung YH, Kim JA, Park NH, Lyu MS, Song IH,Komatsoulis G, Buetow KH. Genome-wide Transcriptional Sequencing Identifies Novel Mutations in Metabolic Genes in Human Hepatocellular Carcinoma. Cancer Genomics Proteomics. 2014;11(1):1-12.(공동저자) (IF 2.8)
- Lee DH, Lee JH, Kim YJ, Park NH, Cho Y, Lee YB, Yoo JJ, Lee M, Cho YY, Choi WM, Yu SJ, Yoon JH, Kim CY, Lee HS. Relationship between polymorphisms near the IL28B gene and spontaneous HBsAg seroclearance: a systematic review and meta-analysis. J Viral Hepat. 2014 ;21(3):163-70.
- Kim CJ, Shin JW, Jung SW, Park BR, Cha HJ, Park NH. Mutational analysis of FEN1 Gene in hepatocellular carcinomas. APMIS. 2014;122:663-5. (교신저자)
- Jung SW, Park NH, Shin JW, Park BR, Kim CJ, Lee JE, Shin ES, Kim JA, Chung YH. Prognostic impact of telomere maintenance gene polymorphisms in hepatocellular carcinoma patients with chronic Hepatitis B. Hepatology. 2014; 59;1912-20 (IF 11.7) (교신저자)
- Lai CL, Ahn S, Lee KS, Um SH, Cho Mong, Yoon SK, Lee JW, Park NH, Kweon YO, Sohn JH, Lee JH, Kim JA, Han KH, Yuen MF. Phase IIb Multi-centered Randomized Trial of Besifovir (LB80380) versus Entecavir in Asian Patients with Chronic Hepatitis B. Gut. 2014;63:996-1004 (10.7)
- Kim YJ, Young Kim H, Lee JH, Jong Yu S, Yoon JH, Lee HS, Yong Kim C, Youn Cheong J, Won Cho S, Park Neung Hwa, Lae Park B, Namgoong S, Hyo Kim L, Sub Cheong H, Doo Shin H. A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum Mol Genet. 2013; 22:4233-38.
- Lee BS, Cho YK, Jeong SH, Lee JH, Lee D, Park NH, Ki M; Korean Hepatitis Epidemiology Study Group. Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs. J Med Virol. 2013 Aug;85(8):1327-33.
- Nam HY, Han MW, Chang HW, Lee YS, Lee M, Lee HJ, Lee BW, Lee HJ, Lee KE, Jung MK, Jeon H, Choi SH, Park NH, Kim SY, Kim SW. Radioresistant Cancer Cells Can Be Conditioned to Enter Senescence by mTOR Inhibition. Cancer Res. 2013;73:4267-77
- Bang SJ, Kim BG, Shin JW, Ju HU, Park BR, Kim MH, Kim CJ, Park JH, Jeong ID, Jung SW, Park NH. Clinical course of patients with insufficient viral suppression during entecavir therapy in genotype C chronic hepatitis B. Dig Liver Dis. 2013 (3.054) (교신저자)
- Lee GR, Shin MK, Yoon DJ, Kim AR, Yu R, Park NH, Han IS. Topical application of capsaicin reduces visceral adipose fat by affecting adipokine levels in high-fat diet-induced obese mice. Obesity. 2013;21(1):115-22. (4.284) (교신저자)
- Kim CJ, Lee GR, Shin JW, Jung SW, Park BR, Park NH. Mutational analysis of SATB1 gene in hepatocellular carcinomas. APMIS. 2013;121:1012-4 (1.991) (교신저자)
- Lee SY, Lee GR, Woo DH, Park NH, Cha HJ, Moon YH, Han IS. Depletion of Aurora
- A leads to upregulation of FoxO1 to induce cell cycle arrest in hepatocellular carcinoma cells. Cell Cycle. 2013;12(1):67-75 (5.359)
- Kim do Y, Kim IH, Jeong SH, Cho YK, Lee JH, Jin YJ, Lee D, Suh DJ, Han KH, Park NH, Kang HY, Jung YK, Kim YS, Kim KA, Lee YJ, Lee BS, Yim HJ, Lee HJ, Baik SK, Tak WY, Lee SJ, Chung WJ, Choi SK, Cho EY, Heo J, Kim DJ, Song BC, Kim MW, Lee J, Chae HB, Choi DH, Choi HY, Ki M. A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver Int. 2013;33(4):586-94.
- Lee JH, Chung YH, Kim JA, Shim JH, Lee D, Lee HC, Shin ES, Yoon JH, Kim BI, Bae SH, Koh KC, Park NH. Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma. Cancer. 2013;119(1):136-42. (4.771)
- Kwon JH, Bae SH, Lee YJ, Lee JW, Kim YS, Hwang JS, Tak WY, Jang JW, Lee BS, Lee JS, Lee CK, Baik SK, Park NH, Lee TH, Kim DJ, Choi JS, Shin JG, Yim HW. The virological response in Koreans infected with HCV genotype 1 did not differ between groups treated with a full dose or reduced dose (≥80 % full dose) of peginterferon alfa-2a: a prospective randomized multicenter trial. Hepatol Int. 2013 Oct;7(4):1000-9.
- Shin JW, Jung SW, Park BR, Kim CJ, Eum JB, Kim BG, Jeong ID, Bang SJ, Lee SH, Kim SR, Park NH. Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels. J Viral Hepat. 2012;19(10):724-31.(4.088) (교신저자)
- Jung SW, Park NH, Shin JW, Park BR, Kim CJ, Lee JE, Shin ES, Kim JA, Chung YH. Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival. J Hepatol. 2012;57(3):621-7.(IF 10.6) (교신저자)
- Won M, Jun EJ, Khim M, Hong SH, Park NH, Kim YK, Lee H. Antiviral protection against enterovirus 71 mediated by autophagy induction following FLICE-inhibitory protein inactivation. Virus Res. 2012;169(1):316-20.(2.941)
- Kim GH, Lee GR, Choi HI, Park NH, Chung HT, Han IS. Overexpression of bone morphogenetic protein 4 in STO fibroblast feeder cells represses the proliferation of mouse embryonic stem cells in vitro. Exp Mol Med. 2012;44(7):457-63.(2.481)
- Ahn J, Woo HN, Ko A, Khim M, Kim C, Park NH, Song HY, Kim SW, Lee H. Multispecies-compatible antitumor effects of a cross-species small-interfering RNA against mammalian target of rapamycin. Cell Mol Life Sci. 2012;69(18):3147-58.(6.570)
- Kim MC, Jung SW, Kim CS, Chung TH, Yoo CI, Park NH. Metabolic syndrome is associated with increased risk of recurrent colorectal adenomas in Korean men. Int J Obes. 2012;36(7):1007-11.(4.691)
- Kim MC, Kim CS, Chung TH, Jeong J, Lee SH, Kim SR, Jung SW, Park NH, Yoo CI. MONW phenotype is associated with advanced colorectal adenoma in Korean men. Obesity. 2012;20(9):1876-81.(4.284)
- Kim CJ, Park NH, Chung YH. Roads towards a new tailored therapy for hepatocellular carcinoma: diagnostic, therapeutic and prognostic implications of microRNAs. Liver Int. 2012;32(5):695-7 (3.824)
- Heo SK, Ju SA, Kim GY, Park SM, Back SH, Park NH, Min YJ, An WG, Nguyen TT, Kim SM, Kim BS. The presence of high level soluble herpes virus entry mediator in sera of gastric cancer patients. Exp Mol Med. 2012;44(2):149-58
- Shin JW, Jung SW, Park BR, Kim CJ, Eum JB, Kim BG, Du Jeong I, Bang SJ, Park NH. HBV DNA level at 24 weeks is the best predictor of virological response to adefovir add-on therapy in patients with lamivudine resistance. Antivir Ther. 2012;17(2):387-94.(3.161)(교신저자)
- Lee SJ, Shin JW, Park BR, Kim CJ, Jung SW, Kim B, Jeong ID, Bang SJ, Park NH. The expression kinetics of CD137 in chronic hepatitis C patients treated with pegylated-interferon and ribavirin. Scand J Gastroenterol. 2012;47(5):601-6 (2.019)
- Lee SH, Chung YH, Kim JA, Lee D, Jin YJ, Shim JH, Jang MK, Cho EY, Shin ES, Lee JE, Park NH, Yu E, Lee YJ. Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinoma. Liver Int. 2012;32(3):457-66
- Huh HC, Lee SY, Lee SK, Park NH, Han IS. Capsaicin induces apoptosis of cisplatin-resistant stomach cancer cells by causing degradation of cisplatin-inducible Aurora-A protein. Nutr Cancer. 2011;63(7):1095-103 (2.783)
- Kim MC, Jung SW, Shin JW, Park NH. The Level of HBV DNA at Month 12 Is an Important Predictor of Virological Breakthrough During Adefovir Monotherapy in Chronic Hepatitis B Patients with Lamivudine Resistance. Dig Dis Sci. 2011;56(4):1215-21 (2.117) (교신저자)
- Jeong ID, Jung SW, Bang SJ, Shin JW, Park NH, Kim DH. Endoscopic enucleation for gastric subepithelial tumors originating in the muscularis propria layer. Surg Endosc. 2011 Feb;25(2):468-74.
- Clifford RJ, Zhang J, Meerzaman DM, Lyu MS, Hu Y, Cultraro CM, Finney RP, Kelley JM, Efroni S, Greenblum SI, Nguyen CV, Rowe WL, Sharma S, Wu G, Yan C, Zhang H, Chung YH, Kim JA, Park NH, Song IH, Buetow KH. Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology. 2010 Dec;52(6):2034-43. (11.665)
- Song BC, Cui XJ, Shin JW, Park NH, Cho YK, Song HJ, Hyun S, Jeong SU, Choi EK, Kim HU. Response to adefovir depends on mutation patterns in precore region, basal core promoter and reverse transcriptase, and on-treatment responses in Lamivudine-resistant chronic hepatitis B patients. Intervirology. 2010;53(4):203-10. (2.337)
- Jung SW, Jeong ID, Bang SJ, Shin JW, Park NH, Kim do H. Successful outcomes of endoscopic resection for gastric adenomas and early cancers located on the pyloric ring (with video). Gastrointest Endosc. 2010 Mar;71(3):625-9.
- Park NH, Chung YH, Lee HS. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period. Intervirology. 2010;53(1):20-8.
- Lee JS, Park ET, Kang SS, Gu ES, Kim JS, Jang DS, Lee KS, Lee JS, Park NH, Bae CH, Baik SK, Yu BJ, Lee SH, Lee EJ, Park SI, Bae M, Shin JW, Choi JH, Gu C, Moon SK, Chun GJ, Kim JH, Kim HS, Choi SK. Clevudine demonstrates potent antiviral activity in naïve chronic hepatitis B patients. Intervirology. 2010;53(2):83-6.
- Shin JW, Park NH, Jung SW, Kim BC, Kwon SH, Park JS, Jeong ID, Bang SJ, Kim DH. Clinical usefulness of sequential measurement of HBV DNA levels (the roadmap concept) during adefovir treatment in patients with lamivudine resistance. Antivir Ther 2009;14:181-186 (교신저자)
- Lee Y-S, Chung YH, Ryu SH, Lee JK, Kim JA, Shin JW, Jang MK, Park NH, Lee HC, Lee YS, Suh DJ. Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy. Liver Int. 2009; 29:552-556
- Ryu SH, Chung YH, Lee JK, Kim JA, Shin JW, Jang MK, Park NH, Lee HC, Lee YS, Suh DJ. Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis. Liver Int. 2009; 29:308-314
- Park NH, Song IH, Chung YH. Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma. Gut Liver. 2007 Dec;1(2):101-17.(0.829)
- Nam CW, Park NH, Park BR, Shin JW, Jung SW, Na YW, Seo JH. Mitotic checkpoint gene MAD1 in hepatocellular carcinoma is associated with tumor recurrence after surgical resection. J Surg Oncol. 2008;97(7):567-71 (2.100) (교신저자)
- Nam CW, Shin JW, Park NH. Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea. World J Gastroenterol. 2008;14(22):3526-33. (2.471) (교신저자)
- Kim H, Park JH, Shin SJ, Kim MJ, Bang SJ, Park NH, Nah YW, Nam CW, Joo KR, Min YJ Fixed dose rate infusion of gemcitabine with oral doxifluridine and leucovorin for advanced unresectable pancreatic cancer: a phase II study. Chemotherapy. 2008;54(1):54-62.
- Bang SJ, Choi SH, Park NH, Shin JW, Choy N, Kim SH, Kim Y. High pallidal T1 signal is rarely observed in obstructive jaundice, but is frequently observed in liver cirrhosis. J Occup Health. 2007;49(4):268-72.
- Kwon SH, Cha HJ, Jung SW, Kim BC, Park JS, Jeong ID, Lee JH, Nah YW, Bang SJ, Shin JW, Park NH, Kim DH. A gastrointestinal stromal tumor of the duodenum masquerading as a pancreatic head tumor. World J Gastroenterol. 2007;13(24):3396-9
- Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive. World J Gastroenterol 2006;12:6693-6698. (교신저자)
- Chronic hepatitis B in hepatocarcinogenesis. Postgrad Med J 2006;82:507-515 .(1.939) (교신저자)
- Metastasis of hepatocellular carcinoma to the small bowel manifested by intussusception. World J Gastroentero 2006;12:1969-1971.
- Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg positive chronic hepatitis B. J Viral Hepat 2005;12(4):393-7. (교신저자)
- Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy. J Gastroenterol Hepatol 2005;20(6):844-9.(2.865)
- Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B. J Viral Hepat 2005;12(2):216-221 (교신저자)
- Whole blood and red blood cell manganese reflected signal intensities of T1-weighted magnetic resonance images better than plasma manganese in liver cirrhotics. J Occup Health 2005;47(1):68-73
- Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy. J Gastroenterol Hepatol 2004;19(12):1363-8.
- Characteristic clinical features of hepatocellular carcinoma associated Budd-Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2004;16(3):319-24.(1.757)
- Whole blood managanese correlates with high signal intensities on T1-weighted MRI in patients with liver cirrhosis. Neurotoxicology 2003;24(6):909-15.
- Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study. J Hepatol 2003;39(4):614-9.
- Close correlation of p53 mutation to microvascular invasion in hepatocellular carcinoma. J Clin Gastroenterol 2001; 33:397-401. (3.159)
- The Role of Bile carcinoembryonic Antigen in Diagnosing Bile Duct Cancer. J Korean Med Sci 2003;18(6):855-858.
- Hwang YT, Shin JW, Lee JH, Hwang DS, Eum JB, Choi HJ, Park NH. A case of fulminant hepatic failure secondary to hepatic metastasis of small cell lung carcinoma. Korean J Hepatol. 2007:13(4):565-70. Korean
- Park NH, Song IH, Chung Y-H. Molecular Mechanisms of Hepatitis B Virus-associated Hepatocellular Carcinoma. Korean J Hepatol. 2007 Sep;13(3):320-40.
- Park NH. Does smoking affect the liver? Korean J Hepatol 2007 (2):248-50
- Han DH, Park NH, Shin JW, Jung SW, Hwang YT, Kim HS, Jeong ID, Bang SJ, Kim DH. Clinical outcomes of lamivudine therapy in HBeAg positive chronic hepatitis B with minimally elevated ALT. Korean J Hepatol. 2007;13(2):146-56
- Endoscopic Mucosal Resection in Early Gastric Cancer Involving Duodenum. A. Korean J Gastrointest Endosc 2005;31(3):166-170.
- Endoscopically Exposed Coil after Embolization for Bleeding Duodenal Ulcer Korean J Gastrointest Endosc 2005;30(1):39-42. Korean.
- Santorinicele Containing a Pancreatic Duct Stone in a Patient with Incomplete Pancreas Divisum. Yonsei Med J 2004;45(4):952-955. English.
- Relationship of Biological Indices of Manganese with Pallidal Index on MR in Liver Cirrhotics. Korean J Occup Environ Med 2004;16(2):129-138.
- Infestation state of clonorchis sinensis in patients with pancreatobiliary disease in ulsan: based on bile examination. Korean J Med 2004;66(5):521-525.
- A Case of Juxtapapillary Duodenal Duplication Cyst Manifested by Recurrent Pancreatitis. Korean J Gastrointest Endosc 2004;28(4):218-222.
- Predictive Factors and Clinical Outcome of Viral Breakthrough during Lamivudine Treatment for Chronic Hepatitis B Infection. Korean J Hepatol 2003;9(4):293-303.
- Diagnostic role of biliary carcinoembryonic antigen in patient with pancreatobiliary disease. Korean J Med 2003;65(5):520-526.
- Predictive factors and efficacy of lamivudine treatment in chronic hepatitis B infection. Korean J Hepatol 2003;9(4):293-303.
- Diagnostic Usefulness of Intradermal Test for Clonorchiasis in Patients with Pancreatobiliary Disease. Korean J Gastroenterol 2003;42(3):232-236.
- Efficacy of Lamivudine Re-treatment and Relapse Patterns after Initial Lamivudine Treatment for Chronic Hepatitis B Infection. Korean J Hepatol 2003;9(3): 188-197.
- Clinical Characteristics and Endoscopic Findings of Impacted Papillary Stone. A. Korean J Gastrointest Endosc 2003;26(6):410-417.
- Efficacy of Lamivudine in Patients with Hepatitis B e Antigen-Negative Chronic Liver Disease. Korean J Hepato 2003;9(2):69-78.
- A Case of Anomalous Insertion of the Common Bile Duct and Pancreatic Duct with Peculiar Cholangiopancreatographic Finding. Korean J Gastroenterol 2003;41(5):414-416.
- Methylation of the p16 tumor suppressor gene in Korean patients with colon cancer and adenoma. Korean J Med 2003;64(4):396-404.
- The Effects of Tamoxifen on Human Hepatocelluar Carcinoma Cell Proliferation and Transforming Growth Factor-beta1 Expression. Korean J Hepatol 2003;9(1):10-16.
- A Case of Simultaneous Xanthogranulomatous Cholecystitis and Carcinoma of the Gallbladder. Korean J Intern Med 2003;18(1):53-56.
- Choi, H.M., Kim, Y.W., Lee, K.H., Lee, S.H., Park.N.H., Ji, S.K., Cha, T.J., Joo, S.J., Lee, J.H. On-line assessment of left ventricular volume and ejection fraction by automated border detection echocardiography. Kor J Cardio 25;1063-1071, 1995
- JI, S.K., Park, N.H., Choi, H.M., Kim, Y.W., Lee, S.H., Lee, K.H., Ahn, S.Y., Lee, S.U., Han, B.Y., Park, B.C. Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma. Kor J Int Med 11; 58-68, 1996.
- Park, N.H., JI, S.K., Choi, H.M., Kim, Y.W., Lee, S.H., Lee, K.H., Yang, S.H., Rim, H., Lee, J.W., Lee, S.D. The effect of immunological alterations induced by donor specific transfusion on the transplanted kidney treated with cyclosporin-A. Kor J Int Med 50;669-677, 1996.
- Park, N.H., Lee, G.C., Yang, S.H., Kang, G.H., Yu, E., Chung, Y-H., Lee, Y.S., Suh, D.J. A clinical study of autoimmune cholangitis. Kor J Gastroenterol 30:786-794, 1997
- Myung, S.J., Lee, Y.S., Kim, H.G., Lee, G.C., Park, N.H., Chung, Y-H., Suh, D.J. Demonstration of hepatitis B virus DNA by polymerase chain reaction in peripheral blood mononuclear cells after recovery from viral hepatitis. Kor J Gastroenterol 29:74-84, 1997
- Kim, M.H., Park, N.H. Ki-ras mutation and p53 protein expression in intrahepatic cholangiocarcinomas arising in hepatolithiasis. Kor J Gastroenterol 30:655-663, 1997
- Suh, D.J., Park, N.H., Chung, Y-H., Lee, Y.S. Efficacy of combination of interferon α2a, ribavirin and UDCA in the treatment of chronic hepatitis C. Kor J Hepatol 2:109-119, 1998
- Kim, D.H., Park, N.H., Chung, Y-H., Lee, Y.S. Suh, D.J. Transjugular liver biopsy: the adequacy and safety. Kor J Int Med 2:153-157, 1998
- Kang, G.H., Park, N.H., Chung, Y-H., Lee, Y.S. Suh, D.J. Yu, E. Cinicopathologic comparison between autoimmune cholangitis and primary biliary cirrhosis. Kor J Pathol 32:115-124, 1998
- Lee, G.C., Kim, H.G., Park, N.H., Won, S.Y., Chung, Y-H., Lee, Y.S., Suh, D.J. Distribution of C virus genotypes determined by line probe assay in Korean patients with chronic HCV infection. Kor J Hepatol 4:244-253, 1998
- Jung. S.A., Chung, Y-H, Park, N.H., Lee, S.S., Kim, J.A., Yang, S.H., Song, I.H., Lee, Y.S., Suh, D.J. Experimental model of hepatic fibrosis following repeated periportal necrosis induced by allylalcohol. Kor J Gastroenterol 34:619-631, 1999
- Park, N.H., Lee, G.C., Yang, S.H., Kang, G.H., Yu, E., Chung, Y-H., Lee, Y.S., Suh, D.J. Comparison of clinical features and response to ursodeoxycholic acid therapy in autoimmune cholangitis and primary biliary cirrhosis. Kor J Gastroenterol 33:548-556, 1999
- Ko, M.S., Chung,Y-H, Song, I.H., Choo, Y.H., Lee, G.C., Park, N.H., An, G.S., Kim, J.A., Lee, Y.S., Suh, D.J., Yoo, B.C. Albumin mRNA in peripheral bloods and a marker of extrahepatic metastasis in patients with hepatocellular carcinoma. Kor J Gastroenterol 33:240-251, 1999
- Jung, S.A., Chung, Y-H., Park, N.H., Lee, S.S., Kim, J.A., Yang, S.H., Song, I.H., Lee, Y.S., Suh, D.J., Moon, I.H.. Experimental model of hepatic fibrosis following repeated periportal necrosis induced by allyalcohol. Scand J Gastroenterol 35:969-75, 2000
- Park, N.H., Chung, Y-H., Youn, K.H., Song, B.C., Yang, S.H., Kim, J.A., Lee, H.C., Yu, E., Lee, Y.S., Lee, S.G., Kim, K.W., Suh, D.J. Close correlation of p53 mutation to microvascular invasion in hepatocellular carcinoma. J Clin Gastroenterol 33:397-401, 2001
- Park, N.H., Joo, K.R., Kim, D.H. The Effect of lamivudine therapy for chronic liver disease due to hepatitis B virus infection. Kor J Hepatol 7:77-89, 2001
- Kim, D.H., Park, N.H., Joo, K.R., Lee, S.H., Kim, S.R., Yoo, C.I., Suh, J.H., Park, J.H. Intragastric bile acid concentration and intestinal metaplasia in the gastric mucos. Kor J Gastroenterol 39:238-242, 2002
- Min, Y.J., Joo, K.R., Park, N.H., Yun, T.K., Nah, Y.W., Nam, C.W., Park, J.H. Gemcitabine therapy in patients with advanced pancreatic cancer. Kor J Int Med 17, 2002
- Kim, D.H., Cho, M., Kim, D.H., Joo, K.R., Park, N.H., Yang, U.S. Methylation of the p16 tumor suppressor gene in Korean patients with colon cancer and adenoma. Kor J Int Med 64, 2003
- Shin, J.W., Chung, Y-H., Park, M.I., Kim, J.A., Choi, M.H., Lee, Y.J., Ryu, S.H., Park, N.H., Lee, H.C., Lee, Y.S., Suh, D.J., Yu, E. The Effects of tamoxifen on human hepatocelluar carcinoma cell proliferation and transforming grwoth factor-β1 expression. Kor J Hepatol 9, 2003
언론
-
등록된 언론이 없습니다.
언론
등록된 영상이 없습니다.